Prelude Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $639K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.25M | Buy |
|
|||||
|
2023
Q2 | $433K | Buy |
|
|||||
|
2023
Q1 | $319K | Sell |
|
|||||
|
2022
Q4 | $617K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.8M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $416K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.2M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $286K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.61M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $214K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $9K | Sell |
|
|||||
|
2017
Q1 | $85K | Buy |
|
|||||
|
2016
Q4 | $41K | Sell |
|
|||||
|
2016
Q3 | $639K | Buy |
|
|||||
|
2016
Q2 | $406K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $141K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $519K | Buy |
|
|||||
|
2015
Q1 | $449K | Sell |
|
|||||
|
2014
Q4 | $616K | Sell |
|
|||||
|
2014
Q3 | $847K | Buy |
|
|||||
|
2014
Q2 | $245K | Buy |
|
|||||
|
2014
Q1 | $209K | Hold |
|
|||||
|
2013
Q4 | $194K | Buy |
|